These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23827202)

  • 1. Effects of group II and III metabotropic glutamate receptor ligands on conditioned taste aversion learning.
    Klakotskaia D; Ramsey AK; Fowler SW; Serfozo P; Simonyi A; Schachtman TR
    Behav Brain Res; 2013 Sep; 253():9-16. PubMed ID: 23827202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats.
    Pałucha-Poniewiera A; Pilc A
    Behav Brain Res; 2013 Feb; 238():109-12. PubMed ID: 23085340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.
    Summa M; Di Prisco S; Grilli M; Usai C; Marchi M; Pittaluga A
    Neuropharmacology; 2013 Mar; 66():215-24. PubMed ID: 22564442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in rats.
    Bahi A; Fizia K; Dietz M; Gasparini F; Flor PJ
    Addict Biol; 2012 Mar; 17(2):235-47. PubMed ID: 21392179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
    Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
    Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of metabotropic glutamate receptor 7 allosteric agonist N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway.
    Wang WY; Wang H; Luo Y; Jia LJ; Zhao JN; Zhang HH; Ma ZW; Xue QS; Yu BW
    Neuroscience; 2012 Mar; 205():167-77. PubMed ID: 22244976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodents.
    Hikichi H; Murai T; Okuda S; Maehara S; Satow A; Ise S; Nishino M; Suzuki G; Takehana H; Hata M; Ohta H
    Eur J Pharmacol; 2010 Aug; 639(1-3):106-14. PubMed ID: 20371227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
    Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
    Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPEP, a selective metabotropic glutamate receptor 5 antagonist, attenuates conditioned taste aversion in rats.
    Schachtman TR; Bills C; Ghinescu R; Murch K; Serfozo P; Simonyi A
    Behav Brain Res; 2003 May; 141(2):177-82. PubMed ID: 12742254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different disruptive effects on the acquisition and expression of conditioned taste aversion by blockades of amygdalar ionotropic and metabotropic glutamatergic receptor subtypes in rats.
    Yasoshima Y; Morimoto T; Yamamoto T
    Brain Res; 2000 Jun; 869(1-2):15-24. PubMed ID: 10865054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the metabotropic glutamate receptor7 (mGlu
    Kotlinska JH; Lopatynska-Mazurek M; Gawel K; Gabka P; Jenda-Wojtanowska M; Kruk-Slomka M; Marszalek-Grabska M; Danilczuk Z; Kedzierska E; Talarek S; Listos J; Gibula-Tarlowska E
    Eur J Pharmacol; 2019 Sep; 858():172512. PubMed ID: 31260653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for Modulating Pain-evoked Activities of Neurons in the Hippocampal CA3 Region of Rats.
    Wei X; Yang D; Shi T; Wang J; Deng Y; Qiao X; Yang C; Xu M
    CNS Neurol Disord Drug Targets; 2017; 16(5):610-616. PubMed ID: 27488423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.
    Domin H; Jantas D; Śmiałowska M
    Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
    Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
    J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
    Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
    J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of mGlu₇ receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains.
    O'Connor RM; Cryan JF
    Behav Pharmacol; 2013 Apr; 24(2):105-13. PubMed ID: 23455446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice.
    Hikichi H; Nishino M; Fukushima M; Satow A; Maehara S; Kawamoto H; Ohta H
    Eur J Pharmacol; 2010 Aug; 639(1-3):99-105. PubMed ID: 20371235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mGlu(2) receptor-mediated modulation of conditioned avoidance behavior in rats.
    Megens AA; Hendrickx HM; Hens KA; Talloen WJ; Lavreysen H
    Eur J Pharmacol; 2014 Mar; 727():130-9. PubMed ID: 24486391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.